Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|February 4, 2020
IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future PerspectivesCaterina Mancarella, Katia ScotlandiJournal of Molecular Endocrinology|December 24, 2017
IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapyCaterina Mancarella, Katia ScotlandiCells|August 27, 2021
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic OptionsCaterina Mancarella, Andrea Morrione, Katia ScotlandiInternational Journal of Molecular Sciences|June 19, 2024
Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic ApproachesCaterina Mancarella, Andrea Morrione, Katia ScotlandiBiomolecules|March 6, 2021
Novel Regulators of the IGF System in CancerCaterina Mancarella, Andrea Morrione, Katia ScotlandiInternational Journal of Molecular Sciences|November 25, 2023
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in SarcomasCaterina Mancarella, Andrea Morrione, Katia ScotlandiCancers|November 11, 2022
CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common CancersCaterina Mancarella, Marianna Carrabotta, Lisa Toracchio, et al.International Journal of Molecular Sciences|November 27, 2024
EphA2 in Cancer: Molecular Complexity and Therapeutic OpportunitiesLisa Toracchio, Marianna Carrabotta, Caterina Mancarella, et al.Frontiers in Endocrinology|June 2, 2015
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell LinesCecilia Garofalo, Mariantonietta Capristo, Caterina Mancarella, et al.Frontiers in Endocrinology|May 8, 2018
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1RCaterina Mancarella, Michela Pasello, Maria Cristina Manara, et al.Pageof 3